Status:

NOT_YET_RECRUITING

Safety of the IPERF Femoral Arterial Cannula in Patients Undergoing Planned Cardiac Surgery With Extracorporeal Circulation Via Femoral Approach

Lead Sponsor:

IPERF SAS

Collaborating Sponsors:

European Cardiovascular Research Center

Conditions:

Cardiac Surgery

Ischemia Limb

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a first-in-human, prospective, single-arm, phase I clinical study evaluating the safety of the iPerf femoral arterial cannula in patients undergoing planned cardiac surgery requiring extracorp...

Detailed Description

This is a first-in-human, prospective, single-arm, phase I clinical study evaluating the safety of the iPerf femoral arterial cannula in patients undergoing planned cardiac surgery requiring extracorp...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Patient aged 18 years or older
  • Patient able to understand the study procedures, provide written informed consent, and comply with study procedures
  • Patients with planned cardiac surgery requiring the use of an extracorporeal circulation via a femoral approach for a maximum of 6 hours.
  • Patient affiliated to the social security system
  • Exclusion criteria
  • Patient weighting less than 45 kg
  • Patient weighting more than 130 kg
  • Patient with common femoral artery diameter less or equal to 6 mm
  • Patient with a stenosis of the aorta, iliac artery, or femoral artery reducing their diameter of more than 50%
  • Patient with previous vascular or endovascular surgery of the iliac or femoral arteries
  • Patient participating in another interventional study
  • Patients with known arterial dissection
  • Patient who is pregnant at the time of enrollment
  • Patients under judicial protection, guardianship or curatorship or subjects deprived of their liberty by judicial or administrative decision

Exclusion

    Key Trial Info

    Start Date :

    November 1 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 1 2026

    Estimated Enrollment :

    15 Patients enrolled

    Trial Details

    Trial ID

    NCT07163234

    Start Date

    November 1 2025

    End Date

    June 1 2026

    Last Update

    September 9 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hôpital privé Jacques Cartier - Ramsay Santé

    Massy, France, 91300